GeneTether Therapeutics Inc. (CSE: GTTX)

Canada flag Canada · Delayed Price · Currency is CAD
0.0800
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST
300.00%
Market Cap 3.10M
Revenue (ttm) n/a
Net Income (ttm) -941.56K
Shares Out 38.74M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,875
Open 0.0800
Previous Close 0.0800
Day's Range 0.0800 - 0.0800
52-Week Range 0.0150 - 0.1100
Beta 2.07
Analysts n/a
Price Target n/a
Earnings Date Mar 28, 2025

About GeneTether Therapeutics

GeneTether Therapeutics Inc., a biopharmaceutical company, focuses on the development of precision gene editing therapies based on its GeneTether platform for human therapeutics applications. It is developing gene therapies for the treatment of patients with rare and monogenic kidney and skin diseases. The company was founded in 2018 and is based in Kelowna, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2018
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol GTTX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.